Using a dataset of combined protein expression with drug IC50s involving 544 compounds and 621 treatments (Figure 2), we looked for associations of protein expression with drug responses across cancer cell lines, involving the three kinase genes—MAP3K2, MASTL, and TTK—that we studied in vitro in uterine cancer cell lines [1]. The gene discussed is MASTL; the disease is cancer.